OncoSec Medical Incorporated ("OncoSec") (NASDAQ:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, will present new clinical data on ImmunoPulse® IL-12 (intratumoral...

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that an abstract describing new data for IPI-549, an orally administered immuno-oncology development candidate that selectively...

Salient CRGT's Senior Vice President and Chief Human Resources Officer Kay Curling will speak alongside TKC Holdings' Director of Human Resources Support Dawn Hammond on a panel, Three Winning...

Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants, today announced that James Watson, Chief Business Officer, will present...

In connection with its Nu Skin LIVE! global convention beginning today, Nu Skin Enterprises (NYSE:NUS) provided updated third-quarter 2017 revenue and earnings guidance. The company expects revenue of